{"id":29512,"date":"2024-12-19T10:58:33","date_gmt":"2024-12-19T15:58:33","guid":{"rendered":"https:\/\/myeloma.ca\/?p=29512"},"modified":"2025-08-19T08:28:08","modified_gmt":"2025-08-19T13:28:08","slug":"resultats-chez-les-jeunes-patients-atteints-dun-myelome-ayant-recu-des-traitements-modernes","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2024\/12\/19\/resultats-chez-les-jeunes-patients-atteints-dun-myelome-ayant-recu-des-traitements-modernes\/","title":{"rendered":"R\u00e9sultats chez les jeunes patients atteints d\u2019un my\u00e9lome ayant re\u00e7u des traitements modernes"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Nous sommes heureux de vous faire part d\u2019une \u00e9tude r\u00e9cemment publi\u00e9e, intitul\u00e9e \u00ab <em>Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies : A Canadian Myeloma Research Group Database Study <\/em>\u00bb<strong> <\/strong>(Caract\u00e9ristiques de la maladie et r\u00e9sultats chez 493 jeunes patients atteints d\u2019un my\u00e9lome, ayant re\u00e7u des traitements modernes\u202f: une \u00e9tude de la base de donn\u00e9es du<em> Canadian Myeloma Research Group<\/em>).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\ufeff<\/strong>Cette importante \u00e9tude d\u2019une base de donn\u00e9es canadienne se concentre sur un groupe souvent sous-repr\u00e9sent\u00e9 dans la recherche, soit les patients \u00e2g\u00e9s de 50 ans et moins, qui repr\u00e9sentent environ 10\u202f% des cas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Analysant 493 patients trait\u00e9s entre 2010 et 2022, l\u2019\u00e9tude fait \u00e9tat d\u2019une survie sans progression m\u00e9diane de 45 mois (la survie globale m\u00e9diane n\u2019a pas encore \u00e9t\u00e9 atteinte).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Malgr\u00e9 ces avanc\u00e9es en mati\u00e8re de traitement, ces r\u00e9sultats soulignent l\u2019urgence d\u2019offrir des traitements novateurs qui permettront d\u2019obtenir des r\u00e9ponses plus profondes et plus durables au sein de cette population.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cette \u00e9tude a b\u00e9n\u00e9fici\u00e9 du soutien de My\u00e9lome Canada gr\u00e2ce \u00e0 la Bourse de recherche<strong> <\/strong><a href=\"https:\/\/myeloma.ca\/fr\/science-et-recherche\/recherche-financee-par-myelome-canada\/#bourse-de-recherche-aldo-del-col\" target=\"_blank\" rel=\"noreferrer noopener\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-red-color\">Aldo Del Col 2023<\/mark><\/strong><\/a><strong>,<\/strong> et la Chaire Maryse et William Brock pour la recherche appliqu\u00e9e en greffe de cellules souches du Dr Jean Roy \u00e0 l\u2019Universit\u00e9 de Montr\u00e9al.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.70332\" target=\"_blank\" rel=\"noreferrer noopener\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-red-color\">Lisez l&rsquo;article en cliquant ici (en anglais).<\/mark><\/strong><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nous sommes heureux de vous faire part d\u2019une \u00e9tude r\u00e9cemment publi\u00e9e, intitul\u00e9e \u00ab Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies : A Canadian Myeloma Research Group Database Study \u00bb (Caract\u00e9ristiques de la maladie et r\u00e9sultats chez 493 jeunes patients atteints d\u2019un my\u00e9lome, ayant re\u00e7u des traitements modernes\u202f: une \u00e9tude [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[58],"tags":[],"class_list":["post-29512","post","type-post","status-publish","format-standard","hentry","category-nouvelles-de-myelome-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=29512"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29512\/revisions"}],"predecessor-version":[{"id":29513,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29512\/revisions\/29513"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=29512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=29512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=29512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}